Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2010
10/28/2010US20100273769 Composition and method for the treatment of parkinson's disease
10/28/2010US20100273767 Modulators of 5-ht receptors and methods of use thereof
10/28/2010US20100273766 Substituted oxindol derivatives, medicaments containing said derivatives and use thereof
10/28/2010US20100273760 Topical Pharmaceutical Formulations And Methods Of Treatment
10/28/2010US20100273754 Organic compounds
10/28/2010US20100273753 Organic compounds
10/28/2010US20100273751 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/28/2010US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy
10/28/2010US20100273728 Formulations For The Oral Administration of Therapeutic Agents and Related Methods
10/28/2010US20100273716 New uses for amino acid anticonvulsants
10/28/2010US20100273715 Use of a peptide and an analgesic pharmaceutical agent
10/28/2010US20100273714 Peptide compounds for treating refractory status epilepticus
10/28/2010US20100273701 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
10/28/2010US20100273700 Use of a peptide as a therapeutic agent
10/28/2010US20100272837 Traditional chinese medicinal compositions for treating depression , formulation thereof, method for preparing the same thereof
10/28/2010US20100272812 Rgd-modified alginate microparticles as a drug release system
10/28/2010US20100272800 Orally disintegrating olanzapine tablet
10/28/2010US20100272796 Sustained release aminopyridine composition
10/28/2010US20100272795 Sustained release aminopyridine composition
10/28/2010US20100272794 Pharmaceutical composition of memantine
10/28/2010US20100272787 Amethod of treating neurodegenerative diseases
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272737 Novel Peptides and Protein and Uses Thereof
10/28/2010US20100272731 Engineered anti-il-23p19 antibodies
10/28/2010US20100272729 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272728 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272720 Antibody Fusion Proteins with a Modified FcRn Binding Site
10/28/2010US20100272716 Antibodies to VLA-1
10/28/2010US20100272710 Compositions and methods for treating and preventing aging-associated diseases
10/28/2010US20100272702 Methods and compositions for treating neuropathies
10/28/2010US20100272685 Porcine Adeno-Associated Viruses
10/28/2010US20100272639 Polysaccharide nanoparticles
10/28/2010DE202009012983U1 Neue therapeutische Konzepte für die Behandlung von Fibromyalgien New therapeutic approaches for the treatment of fibromyalgia
10/28/2010CA2759714A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759713A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759706A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
10/28/2010CA2759697A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759621A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759614A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759607A1 Modulators of 5-ht receptors and methods of use thereof
10/28/2010CA2759604A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759547A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759505A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759501A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759490A1 Tissue kallikrein for the treatment of huntington's disease
10/28/2010CA2759481A1 Tissue kallikrein for the treatment of schizophrenia and bipolar disorder
10/28/2010CA2759456A1 Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
10/28/2010CA2759354A1 Method of treating or preventing a convulsive disorder in a patient in need thereof
10/28/2010CA2759160A1 3-azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010CA2758985A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758968A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/28/2010CA2758729A1 Arylsulfonamide ccr3 antagonists
10/28/2010CA2757866A1 Novel amide and amidine derivatives and uses thereof
10/27/2010EP2243779A1 Bicyclic heterocyclic derivative
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2243772A1 Novel P2X7R antagonists and their use
10/27/2010EP2243484A2 Controlled release oxycodone compositions
10/27/2010EP2243481A1 Irak kinase family as novel drug target for Alzheimer
10/27/2010EP2243476A1 Compounds for the treatment of mitochondrial diseases
10/27/2010EP2243475A1 Combination of memantine and donepezil for treatment of CNS disorders
10/27/2010EP2243471A1 Matrix for sustained, invariant and independent release of active compounds
10/27/2010EP2242838A1 Stem-like cells and method for reprogramming adult mammalian somatic cells
10/27/2010EP2242754A1 Novel 9-aza-bicyclo[3.3.1]non-3-yloxy chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2010EP2242748A1 Therapeutic disulfide compounds for treating pain and diabetes
10/27/2010EP2242746A1 Heterocyclically-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof
10/27/2010EP2242745A1 Novel phenyl-substituted imidazolidines, method for the production thereof, medicaments containing said compounds and use thereof
10/27/2010EP2242742A2 Organic compounds
10/27/2010EP2242737A1 Pregabalin salts
10/27/2010EP2091938B1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
10/27/2010EP2046800B1 6-carboxy-normorphinan derivatives, synthesis and uses thereof
10/27/2010EP1922320B1 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
10/27/2010EP1891057B1 Azabicyclo[3.1.0]hexane derivaives as dopamin d3 receptor modulators
10/27/2010EP1742634B1 Polycyclic pyrimidines as potassium ion channel modulators
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1385980B1 Yeast strains autonomously producing steroids
10/27/2010EP1383742B1 Synthesis and methods of use of tetrahydroindolone analogues and derivatives
10/27/2010EP1330293B2 Controlled release composition comprising lactic acid polymer, and method of producing the same
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN1878762B Morpholine derivatives as norepinephrine reuptake inhibitors
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN1671381B Pramipexole once-daily dosage form
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101874028A 2-aza-bicyclo[3.3.0]octane derivatives
10/27/2010CN101874020A Piperidine derivatives as agonists of muscarinic receptors
10/27/2010CN101873857A Mipo inhibitors for the treatment of huntington's disease and multiple system atrophy
10/27/2010CN101873855A Preparation and a component intended to be added to a tobacco product
10/27/2010CN101870692A Novel piperazinyl pyridazine compounds
10/27/2010CN101870684A Scutellarin aglycone derivative for treating vascular dementia and preparation method and application thereof
10/27/2010CN101869672A Moxibustion liquid and preparation process thereof
10/27/2010CN101869660A Tuber fleeceflower root and turtle shell nourishing capsules for treating yin deficiency symptoms
10/27/2010CN101869657A Plaster used together with cigarettes, method for preparing same and ring containing same
10/27/2010CN101869652A Traditional Chinese medicine for treating epilepsy
10/27/2010CN101869651A Chinese medicinal composition for treating depression and insomnia
10/27/2010CN101869633A Enteric-coated medicament combination containing epigallocatechin gallate
10/27/2010CN101869625A Chinese medicament for treating sciatica
10/27/2010CN101869600A Medicinal composition for treating degenerative change in central nervous system, preparation method and application thereof
10/27/2010CN101869592A Formula and preparation method of pollen product
10/27/2010CN101869565A Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
1 ... 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 ... 1833